Repositionable Endoluminal Support Structure with Integrated Synergistic Technologies

A repositionable endoluminal support structure that integrates with distinct technologies such as AI, IoT, blockchain, and novel materials to create a more powerful and adaptive system for endoluminal stenting and prosthetic devices.

The original patent described a repositionable endoluminal support structure for maintaining an open lumen in a vessel or tract. However, it lacked real-time monitoring, adaptability, and secure tracking capabilities. The new inventive concept addresses these limitations by incorporating synergistic technologies to enhance the support structure's performance, safety, and efficacy.

The repositionable endoluminal support structure comprises a plurality of longitudinal strut members interconnected by swivel joints. It is integrated with an artificial intelligence module for real-time monitoring and adjustment of the strut members' rotational angles. The support structure can be deployed using an IoT network, transmitting real-time data to a remote server for feedback and adjustment. Additionally, the support structure can be fabricated from novel shape-memory alloy materials and incorporate MEMS for sensing and responding to environmental changes. A blockchain-based system tracks and verifies the support structure's manufacturing, deployment, and maintenance history. Machine learning algorithms can be used to personalize the support structure design based on a patient's medical history and anatomical data.

The new claims introduce the integration of AI, IoT, blockchain, and novel materials with the repositionable endoluminal support structure, providing real-time monitoring, adaptability, and secure tracking capabilities that are not present in the original patent. These synergistic combinations create a more powerful and adaptive system, overcoming the limitations of the original patent.

Alternative embodiments of the inventive concept could include integrating the support structure with other technologies such as robotics, computer vision, or advanced sensors. Variations could include different strut geometries, materials, or actuation mechanisms to accommodate various anatomical locations and patient needs.

The repositionable endoluminal support structure with integrated synergistic technologies has significant commercial potential in the medical device industry, particularly in the fields of cardiovascular and neurovascular interventions. The target market includes hospitals, clinics, and medical research institutions, with potential applications in personalized medicine, minimally invasive procedures, and remote patient monitoring.